Boston Research & Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.45M Sell
11,465
-462
-4% -$58.4K 0.35% 64
2025
Q1
$1.53M Sell
11,927
-630
-5% -$80.6K 0.38% 62
2024
Q4
$1.66M Hold
12,557
0.41% 61
2024
Q3
$1.83M Sell
12,557
-1,685
-12% -$245K 0.43% 61
2024
Q2
$1.95M Sell
14,242
-545
-4% -$74.8K 0.49% 62
2024
Q1
$2.03M Sell
14,787
-269
-2% -$36.9K 0.5% 62
2023
Q4
$2.05M Sell
15,056
-1,210
-7% -$164K 0.54% 62
2023
Q3
$1.99M Sell
16,266
-20
-0.1% -$2.45K 0.59% 60
2023
Q2
$2.07M Sell
16,286
-53
-0.3% -$6.73K 0.59% 59
2023
Q1
$2.11M Sell
16,339
-57
-0.3% -$7.36K 0.63% 57
2022
Q4
$2.15M Sell
16,396
-305
-2% -$40K 0.67% 56
2022
Q3
$1.95M Buy
16,701
+585
+4% +$68.4K 0.67% 58
2022
Q2
$1.9M Buy
16,116
+1,500
+10% +$176K 0.61% 59
2022
Q1
$1.9M Buy
14,616
+630
+5% +$82.1K 0.55% 61
2021
Q4
$2.13M Buy
13,986
+300
+2% +$45.8K 0.58% 60
2021
Q3
$2.21M Buy
13,686
+465
+4% +$75.2K 0.66% 58
2021
Q2
$2.16M Buy
13,221
+290
+2% +$47.4K 0.66% 55
2021
Q1
$1.95M Buy
12,931
+235
+2% +$35.4K 0.63% 56
2020
Q4
$1.92M Buy
12,696
+105
+0.8% +$15.9K 0.67% 55
2020
Q3
$1.7M Sell
12,591
-605
-5% -$81.9K 0.67% 52
2020
Q2
$1.8M Buy
13,196
+187
+1% +$25.6K 0.75% 50
2020
Q1
$1.4M Sell
13,009
-425
-3% -$45.8K 0.7% 49
2019
Q4
$1.62M Buy
13,434
+150
+1% +$18.1K 0.61% 52
2019
Q3
$1.32M Buy
13,284
+1,265
+11% +$126K 0.52% 53
2019
Q2
$1.31M Buy
12,019
+575
+5% +$62.7K 0.53% 55
2019
Q1
$1.28M Buy
11,444
+630
+6% +$70.4K 0.53% 54
2018
Q4
$1.04M Sell
10,814
-1,685
-13% -$162K 0.5% 54
2018
Q3
$1.52M Buy
12,499
+655
+6% +$79.9K 0.7% 52
2018
Q2
$1.3M Buy
11,844
+3,330
+39% +$366K 0.64% 53
2018
Q1
$908K Buy
8,514
+3,555
+72% +$379K 0.46% 60
2017
Q4
$529K Buy
+4,959
New +$529K 0.27% 69